![](/img/cover-not-exists.png)
PDB37 THE COST-EFFECTIVENESS OF SAXAGLIPTIN VERSUS NPH INSULIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) IN POLAND
K Kolasa, M Niewada, J Puelles Fernandez de Troconiz, R Townsend, P McEwanVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(11)72095-2
File:
PDF, 77 KB
english, 2010